tiprankstipranks
Livzon Pharmaceutical Group Class H (LVZPF)
:LVZPF
US Market

Livzon Pharmaceutical Group (LVZPF) Stock Forecast & Price Target

Compare
5 Followers
See the Price Targets and Ratings of:

LVZPF Financial Forecast

LVZPF Earnings Forecast

Next quarter’s earnings estimate for LVZPF is $0.06 with a range of $0.05 to $0.06. The previous quarter’s EPS was $0.07. LVZPF beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 36.60% of the time in the same period. In the last calendar year LVZPF has Outperformed its overall industry.
Next quarter’s earnings estimate for LVZPF is $0.06 with a range of $0.05 to $0.06. The previous quarter’s EPS was $0.07. LVZPF beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 36.60% of the time in the same period. In the last calendar year LVZPF has Outperformed its overall industry.

LVZPF Sales Forecast

Next quarter’s sales forecast for LVZPF is $382.47M with a range of $382.47M to $382.47M. The previous quarter’s sales results were $386.47M. LVZPF beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 55.33% of the time in the same period. In the last calendar year LVZPF has Preformed in-line its overall industry.
Next quarter’s sales forecast for LVZPF is $382.47M with a range of $382.47M to $382.47M. The previous quarter’s sales results were $386.47M. LVZPF beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 55.33% of the time in the same period. In the last calendar year LVZPF has Preformed in-line its overall industry.

Detailed List of Analyst Forecasts​

Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Morgan Stanley
$3.08$2.95
Sell
-12.07%
Downside
Reiterated
10/25/24
Livzon Pharmaceutical Group Inc. (1513:HK) (LVZPF) PT Lowered to HK$23 at Morgan StanleyMorgan Stanley analyst Sean Wu lowered the price target on Livzon Pharmaceutical Group Inc. (1513:HK) (OTC: LVZPF) to HK$23.00 (from HK$24.00) while maintaining a Underweight rating.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Livzon Pharmaceutical Group

Which Analyst Should I Follow If I Want to Buy LVZPF and Sell After:
1 Month
xxx
Success Rate
1/4 ratings generated profit
25%
Average Return
+1.85%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 25.00% of your transactions generating a profit, with an average return of +1.85% per trade.
3 Months
xxx
Success Rate
3/4 ratings generated profit
75%
Average Return
+5.42%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 75.00% of your transactions generating a profit, with an average return of +5.42% per trade.
1 Year
Sean Wu CFAMorgan Stanley
Success Rate
3/4 ratings generated profit
75%
Average Return
+5.42%
reiterated a sell rating 4 months ago
Copying Sean Wu CFA's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +5.42% per trade.
2 Years
xxx
Success Rate
3/4 ratings generated profit
75%
Average Return
+6.75%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 75.00% of your transactions generating a profit, with an average return of +6.75% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

LVZPF Analyst Recommendation Trends

Rating
Sep 22
Sep 23
Oct 23
Jan 24
Oct 24
Strong Buy
1
0
1
2
2
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
2
3
2
1
2
Strong Sell
0
0
0
0
0
total
3
3
3
3
4
In the current month, LVZPF has received 2 Buy Ratings, 0 Hold Ratings, and 2 Sell Ratings. LVZPF average Analyst price target in the past 3 months is $2.95.
Each month's total comprises the sum of three months' worth of ratings.

LVZPF Stock Forecast FAQ

What is LVZPF’s average 12-month price target, according to analysts?
Based on analyst ratings, Livzon Pharmaceutical Group Class H’s 12-month average price target is $2.95.
    What is LVZPF’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for LVZPF, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is LVZPF a Buy, Sell or Hold?
        Livzon Pharmaceutical Group Class H has a consensus rating of Moderate Sell which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
          What is Livzon Pharmaceutical Group Class H’s price target?
          The average price target for Livzon Pharmaceutical Group Class H is $2.95. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst price target is $2.95 ,the lowest forecast is $2.95. The average price target represents -12.20% Decrease from the current price of $3.36.
            What do analysts say about Livzon Pharmaceutical Group Class H?
            Livzon Pharmaceutical Group Class H’s analyst rating consensus is a Moderate Sell. This is based on the ratings of 0 Wall Streets Analysts.
              How can I buy shares of LVZPF?
              Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis